MET and lung cancer: Human microarray analysis revealed that oleocanthal-treated A549-Luc lung cancer tissues had a distinct gene signature that confirmed the dual targeting of c-Met and COX-2, thus supporting the potential role of oleocanthal as a valid adjuvant agent for the prevention and treatment of lung cancer [49].